All stock lists
Upstream Bio, Inc. (UPB)
NASDAQ: UPB · Real-Time Price · USD
Healthcare · Biotechnology
$2.15-$0.63 (-22.66%)
Insider Score
34/ 100
UPB Insider Score
Bearish0 qualifying trades · 0 insiders · $0 bought in the last 90 days
UPB analyst forecast
UPB analyst consensus
Moderate Buy1 ratings
Buy 1 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
UPB 12-month price target
$51.00+2272.1% upsideaverage of 1 firm
$51.00High
$51.00Low
Best analysts covering UPB
No firm covering UPB has a call old enough to have finished a 1Y holding period yet.
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
UPB analyst ratings
Filters
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-11-11 |
| — | JP Morgan | Neutral | — | — | Reiterated | 2026-08-14 |
| — | Truist Securities | Buy | — | — | Reiterated | 2026-08-12 |
| — | JP Morgan | Neutral | — | — | Downgraded | 2026-06-12 |
| Mizuho | Outperform | $51.00 | +80.0% | Reiterated | 2026-05-14 | |
| — | Evercore ISI Group | In Line | — | — | Downgraded | 2026-03-27 |
| Mizuho Securities | — | $51.00 | +80.0% | Price target | 2025-12-17 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
